We found that influenza virus had the capacity to replicate in the peritoneal macrophages of normal mice, as revealed by the development of hemadsorption and the appearance intracellularly of S and V antigens. Cell-mediated resistance was studied in mice infected with influenza virus or a bacterial sytem of induction-elicitation. In the homologous system, mice were injected intraperitoneally or exposed by aerosol to a sublethal dose of an egg-adapted swine strain of influenza virus. In the heterologous system, they were (1) .
Defimition: induction and elicitation. By induction, in the present context, is meant the evocation of delayed-type hypersensitivity in response to appropriate antigens, typically of a living pathogenic agent. In the present communication, induction is by repeated infection with living Stapkylococcus aureus.
By elicitation is meant the evocation of lymphokines and the activation of macrophages in response to antigens homologous with the pathogenic agent. In this communication, elicitation is by staphylococcal phage lysate (SPL). More commonly, BCG is used as inducer and BCG, OT, or purified protein derivative as eliciting agent.
Specific induction and stimulation of laboratory animals by certain microorganisms result in activation of macrophages and increased capability of intracellular destruction of unrelated as well as related microorganisms.
With staphylococcal infection in mice, activation of peritoneal cells and significant increases in intracellular destruction by these cells of S. aureus in vitro were demonstrated in mice infected repeatedly with S. aureus and elicited by staphylococcal antigens (16) . Such treated mice also were shown to be protected against challenge with vaccinia virus in vivo (1) .
Although the important role of activated macrophages in bacterial infections has been extensively investigated, the defensive role of these (19) evaluated cellular and humoral immunity in the guinea pig after systemic or local administration of high and low doses of a killed influenza virus vaccine. Also using inhibition of macrophage migration as their indicator system, they examined cells from bronchial washings as well as splenic lymphocytes.
In the present study, it was found that influenza virus had the capacity to poules and frozen at -80 C until used. Before each experiment, the virus egg infectivity titers of these pools were assayed in the usual manner (6) . Its mouse infectivity titers were measured by exposing in an aerosol chamber (see below) a group of six mice each to falling 10-fold dilutions of virus in normal allantoic fluid. The exposed mice, as well as a control group which was exposed to aerosolized normal allantoic fluid, were observed for a period of 12 days. At the end of that time, all survivors were sacrificed. Any animals that died, as well as the killed animals, were examined for the extent of their lung lesions, which were scored 1 through 4 plus. The egg infectivity (EID50) and mouse infectivity and minimal lethal titers (LD50) were computed according to the ReedMuench formula (14) .
Staphylococcal strain. S. aureus strain 18Z described previously (8) was used for infection of mice. Bacterial suspensions were made from 18-h cultures grown in Trypticase soy broth (TSB; Baltimore Biological Laboratories, Baltimore, Md.) and washed twice with 0.85% NaCl containing 1% TSB.
Aerosol chamber. The aerosol chamber had been devised for use in earlier influenza virus research (F. S. Lief and L. Syrucek, unpublished data). It consisted of an air-tight stainless-steel chamber 12 inches (about 30 cm) wide, 19 inches (about 47.5 cm) deep, and 16 inches (about 40 cm) high with a clear 0.5 inch (about 1.25 cm)-thick Plexiglass removable front. The mice were placed in the chamber in shallow wire mesh containers which could be stacked with air spaces in between. At the inlet to the chamber was a glass Vaponephrine nebulizer (Vaponephrine Co., Portland, Ore.) connected to a tank of air under pressure. The flow of air through the nebulizer was controlled by a flow meter. At the terminal end, the air passing through the chamber was sterilized by passage through Wescodyne (West Chemical Products, Inc., New York, N.Y.). In practice, it was found that nebulization of 2 ml of a virus suspension gave highly reproducible results. With a flow of 3 liters of air per min, it required 20 min. At the end of that time, the nebulizer was bypassed and the chamber was flushed with air alone for at least 10 min, after which the chamber was opened and the mice were removed.
Immunization and challenge of mice with influenza virus. For immunization, mice were either inoculated intraperitoneally with 0. Challenge of peritoneal cells with influenza virus. Peritoneal exudate cells collected at the appropriate times after immunization, as well as cells collected simultaneously from normal mice of the same age, were washed three times with Hanks solution before being challenged in vitro with the mouse-adapted swine strain. The washed cells suspended in Hanks solution supplemented with 10% fetal calf serum, 100 U of penicillin, and 100 Ag of streptomycin per ml were challenged with the virus at a multiplicity of 10 EID5. per monocyte. After incubation at 37 C in a spinner culture flask for 60 min to allow for maximal viral adsorption, the infected cell suspensions were repeatedly washed in the cold in order to remove residual virus. On the first centrifugation, the packed cells were resuspended in 2 ml of cold Hanks solution containing 5% fetal calf serum and the antibiotics. This suspension was then transferred to a new centrifuge tube containing 40 ml of the same cold suspending medium and centrifuged. Resuspension in 40-ml volumes and centrifugation were repeated for a total of six times. It was found that little or no extracellular virus remained in the last wash solution, as determined by assays in embryonated chicken eggs. The washed infected cells were immediately suspended in Hanks solution containing 10% fetal calf serum and antibiotics, and 3 x 106 viable cells were introduced into each of a series of Leighton tubes with cover slips and placed at 37 C. At various time intervals, four cover slips with the adherent cells were removed; two were tested for development of hemad- Hemadsorption test. For evaluation of hemadsorption the cells on the cover slips in the tubes were washed with cold Hanks solution and overlayered with 1 ml of a cold 0.5% suspension of guinea pig red cells, after which the tubes were placed at 4 C for 60 min. The cover slips were removed, washed and fixed in methanol, and stained with Giemsa. One thousand monocytes on duplicate cover slips were counted under light microscopy, and the number of monocytes with one, two to five, and more than five red cells attached were recorded.
Determination of S and V antigens by IF. Demonstration of the development of S and V antigens in the infected cells was accomplished by using the indirect IF test (20) . For this purpose the cells on the other two cover slips were similarly washed with Hanks solution and on removal fixed with acetone. One-half of each pair of cover slips was tested for S and the other half for V antigen by using anti-S and anti-V guinea pig sera and fluorescein-tagged antiguinea pig immunoglobulin G prepared in rabbits (Hyland Laboratories. Inc., Costa Mesa, Calif.). The production of pure anti-S and anti-V sera has been described (9, 10) . One thousand cells on the two cover slips were counted, and the number showing fluorescence and the location of the staining were recorded.
The cells recorded in this study were chiefly mononuclear cells adherent to the cover slips. Our data give the percentages of total monocytes on cover slips after staining.
RESULTS
Growth of virus in normal mouse peritoneal cells: development of hemadsorption. Peritoneal cells collected from normal mice were infected in vitro with the mouse-adapted swine strain at a multiplicity of 10 EID50 per cell, as described.
An examination of infected cells immediately after seeding onto the cover slips, i.e., after the periods allowed for adsorption of virus, the washing of the cells to free them from residual virus and for attachment to glass, revealed no evidence of hemadsorption. This interval represented 1.5 h from the time of inoculation (Fig.   1A ). With time, however, hemadsorption did appear and was most pronounced at 5 h (Fig.   1B) . It remained at about the same level up to 18 h after inoculation, after which the experiment was discontinued. Formation of S and V antigens. Although the development of hemadsorption in normal macrophages inoculated with virus suggested the replication of virus within those cells, other means had to be obtained to substantiate the point. The sequential appearance of S and V antigens in the growth cycle of influenza virus in cell cultures as detected by IF has been studied and described (11) . Accordingly, these techniques were applied to our infected macrophages by using anti-S and anti-V guinea pig sera and labeled anti-guinea pig immunoglobulin G as described. As can be seen from Table 2 , which gives the averages from four experiments, in the presence of anti-S serum, no fluorescence was detectable immediately after seeding of the cover slips or 1.5 h after virus exposure. However, some nuclear fluorescence began to appear at 3 h, which became maximal at 4 h, an average of 14% (7 to 26%) showing this type of stain. It subsequently began to decline and all but disappeared by 18 h. In the presence of anti-V serum, on the other hand, cytoplasmic 5 h as compared to those from normal mice, particularly when the cells were derived from aerosol-immunized animals (Fig. 3) .
The results of the indirect immunofluorescent tests substantiated these findings. The percentages producing S antigen by 4 h or V antigen by 5 h were significantly lower in cells from virusimmunized mice (Fig. 4) . Again, the cells from the aerosol-immunized mice were the least responsive and therefore most resistant to viral infection. Indeed, the immunofluorescent test data suggest that the cells from the aerosolimmunized mice were 9 to 10 times more resistant to infection than cells from normal mice.
Growth of virus in cells from mice induced and elicited with the bacterial system. Peritoneal cells from mice infected repeatedly with live S. aureus and elicited with SPL were (Fig. 5) . However, they were slightly more susceptible to the virus than cells from virus-immunized mice. The results of the search for S and V antigens in these cells are shown in Fig. 6 . The percentage containing S antigens in the nucleus at 4 h and V antigen in the cytoplasm at 5 h was also lower in cells from mice infected and elicited with the bacterial system. Roughly two to four times fewer cells from bacterially stimulated mice were apparently able to produce these 10 antigens than cells from normal mice. Here also the cells from bacterially induced and elicited mice were slightly less inhibitory to the virus exposed to a minimal lethal dose of the mouseadapted strain by aerosol, survived longer than normal mice. Figure 7 represents the average percentage of cumulative mortality observed in duplicate experiments; in each experiment, six mice per group were challenged. It can be seen that mice induced and elicited by the bacterial system, especially those mice which were elicited by aerosol, survived longer than normal mice after challenge with influenza virus. Although the mortality rate in these mice was also somewhat decreased, with the numbers of animals tested it could not be considered signifi- (15) demonstrated that BCG vaccination and OT elicitation evoked an interferon response. In the present work, although washed monocytes were used in vitro, the possibility of the presence of some intracellular interferon could not be excluded.
The finding of Hers (7) of bright nuclear and weak cytoplasmic fluorescence in a macrophage recovered from bronchial secretions of a human ill with influenza also suggests that viral replication in macrophages is not limited to an experimental model but may be a factor in the pathogenesis of human disease.
Previous investigators of cell-mediated resistance in relation to influenza virus have employed only killed virus for stimulation and inhibition of macrophage migration as their test system. Feinstone et al. (3) showed that, after the sensitization of their mice by injection into the footpads of killed mumps or influenza vaccines in complete Freund adjuvant, they could demonstrate the inhibition of migration of splenic lymphocytes taken from these mice in the presence of the homologous antigens. The inhibition was somewhat specific. Waldman et al. (19) demonstrated in the guinea pig that the stimulation of cellular resistance was route and dose dependent when a killed commercial influenza vaccine was employed as immunogen. When a dose comparable to that used for man (low dose group) was instilled intranasally, inhibition of macrophage migration became most pronounced in bronchial cells and was feeble in cells isolated from the spleen. The results were exactly reversed with respect to the source of lymphocytes when the mice were immunized systemically. When a significantly higher dose was given, these differences were almost obliterated. However, regardless of the dose, the development of humoral antibody reflected the route of administration, i.e., circulating neutralizing antibody was optimally stimulated by the systemic and secretory neutralizing antibody by the intranasal route.
In our studies using live virus, maximal stimulation of cellular resistance of the peritoneal macrophages occurred after the aerosol route. Under these conditions, of course, virus had the optimal opportunity to multiply and to provide a large antigenic mass for induction of cell-mediated resistance. It was found in an earlier study that mice similarly exposed to the same or other strains of influenza virus developed high levels of circulating antibodies (F. S. Lief and L. Syrucek, unpublished data).
Little is known as to the nonspecific elicitation of cell-mediated resistance with respect to influenza. Myrvik (13) Our observations in vivo on survival after challenge with the swine influenza virus probably do not represent optimal conditions. Although there was some evidence of protection as revealed by increased survival time, perhaps the conditions of exposure and evaluation were not sufficiently sensitive. Possibly exposure to a less lethal concentration of virus and evaluation by lung lesions and/or quantitation of the amount of virus produced would yield more conclusive results.
The findings reported here strengthen the position that the development and functioning of cell-mediated resistance must be considered in evaluating the interaction between a virus, specifically influenza virus, and its intact host.
